Ads
related to: best antibiotic for sheep pneumonia in children under 2 years
Search results
Results From The WOW.Com Content Network
Tilmicosin is a macrolide antibiotic.It is distributed under the brand name Micotil.It is used in veterinary medicine for the treatment of bovine respiratory disease and enzootic pneumonia caused by Mannheimia (Pasteurella) haemolytica in sheep. [3]
A CDC infographic on how antibiotic-resistant bacteria have the potential to spread from farm animals. The use of antibiotics in the husbandry of livestock includes treatment when ill (therapeutic), treatment of a group of animals when at least one is diagnosed with clinical infection (metaphylaxis [1]), and preventative treatment (prophylaxis).
Parasitic bronchitis, also known as hoose, husk, or verminous bronchitis, [1] is a disease of sheep, cattle, goats, [2] and swine caused by the presence of various species of parasite, commonly known as lungworms, [3] in the bronchial tubes or in the lungs. It is marked by cough, dyspnea, anorexia and constipation.
Tylosin is a macrolide antibiotic and bacteriostatic feed additive used in veterinary medicine. It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms. [1] It is found naturally as a fermentation product of Streptomyces fradiae. [2]
Several mechanisms are involved in the pathogenicity of M. ovipneumoniae, including altering macrophage activity, adhering to the ruminants' ciliated epithelium via its polysaccharide capsule, inducing the production of autoantibodies to ciliary antigens, and suppressive activity on lymphocytes, all of which are important factors that contribute to the disease in sheep and other small ruminants.
For premium support please call: 800-290-4726 more ways to reach us
Its use as a prophylactic treatment is supported by one clinical trial involving children with acute lymphoblastic leukaemia. [59] Other than this and one other clinical trial into its efficacy as a treatment for pneumocystis pneumonia, [ 60 ] data on its use in both the treatment and prevention of pneumocystis pneumonia is significantly lacking.
In a study comparing the safety and efficacy of levofloxacin to that of azithromycin or ceftriaxone in 712 children with community-acquired pneumonia, serious adverse events were experienced by 6% of those treated with levofloxacin and 4% of those treated with comparator antibiotics. Most of these were considered by the treating physician to be ...